Healthy Non-Obese Older Adults (2010-2012)
- To develop a practical (i.e., based on easily measured variables) and accurate age-specific equation for predicting resting metabolic rate (RMR) in older women
- Compare (cross-validate) the measured RMR values of the study participants with existing equations for predicting RMR in older females.
- Healthy
- Female
- Age 50-81
- Able to give consent.
- Clinical evidence of CHD (i.e. ST-segment depression greater than 1mm at rest or exercise) or cardiomyopathy)
- Hypertension (blood pressure >140/90mm Hg)
- Medications that could affect cardiovascular function or metabolic rate
- Medical history of diabetes or obesity
- Instability of body weight during previous year
- Exercise-limiting non-cardiac disease (arthritis, peripheral vascular disease, cerebral vascular disease, etc.)
- History of oophorectomy.
Recruitment
Methods not specified
Design
Cross-sectional study
Blinding used
Not used
Intervention
Not applicable
Statistical Analysis
- Regression equations used to examine linear and non-linear relationships between RMR and other independent variables
- Semi-partial F-tests performed to determine whether the quadratic models explained a significantly greater amount of variance in RMR than explained by linear regression models
- Pearson correlation used to assess the degree of association between variables
- Stepwise multiple regression used to predict RMR from the independent variables
- Potential predictors of RMR: Standing height, body weight, body surface area, body mass index, fat mass, fat-free mass, skinfolds, VO2max, leisure time physical activity, daily energy and macronutrient intake, menstrual status, and age
- Practical equations derived in which only easily measured variables were considered: Body weight standing height, age, skinfolds, menstrual status and leisure time physical activity
- Dependent T-test used to compare the measured and predicted means of RMR
- Independent z test used to compare correlation coefficient (r) between predicted RMR and measured RMR with the multiple R obtained from the regression equation of the original study
- Statistical significance was set at P<0.05.
Timing of Measurements
All participants admitted to research center evening before metabolic testing and identical protocol for all participants
Dependent Variable
Resting Metabolic Rate (RMR):
- Measured: Indirect calorimetry (IC)
- IC type: Used ventilated hood technique for 45 minutes
- Rest before measure: IC done under inpatient conditions (in research laboratory and measurements done in same room where participant slept); recent work showed inpatient RMR 8% lower under inpatient conditions compared with outpatient condition
- Measurement length: 45 minutes
- Fasting length: Overnight
- Exercise conditioning 24 hours prior to test? IC 36-48 hours after last exercise bout to minimize the effect of physical activity on RMR
- Room temp: Not reported
- No of measures repeated? Not reported
- Coefficient of variation? Not reported
- Equipment calibration: No machine calibration was mentioned
- Training of measurer? Not reported
- Subject training of measuring process: Participants given practice with ventilated hood the evening before to reduce apprehension with testing conditions
- Estimated RMR: Validity of five commonly used prediction equations tested in this data set:
- WHO/FAO (>60 years)
- Harris-Benedict
- Owen
- Fredrix
- Mifflin.
Independent variables
- Height and weight: Methods not specified
- Body composition:
- Body fat: Underwater weighing to determine body density with simultaneous measurement of residual lung volume by the helium dilution method using the formula of Siri
- Fat free mass (FFM): Total body weight minus fat weight
- Skinfolds: Triceps, chest, abdomen and thigh (Lange skinfold caliper); all measurements taken on right side of body; each value was the mean of three consecutive measurements by same investigator
- Physical activity level: Minnesota Leisure Time Physical Activity Questionnaire
- Maximum aerobic power (VO2 max): progressive and continuos treadmill test to volitional fatigue
- Energy intake: Three-day dietary intake using weighed food records
- Menopausal status: Classified as 1=pre-menopausal (6%); 2=peri-menopausal (6%); or 3=postmenopausal (88%).
- Initial N: Not given
- Attrition (final N): N=75 females
- Age: 61±8 years (50-81)
- Ethnicity: Not reported
- Other relevant demographics: None reported
- Anthropometrics:
| Women | Mean±SD | Range |
|
Weight, kg |
63.3±7 | 51.8-92.3 |
|
Height, cm |
163±7 | 149-178 |
|
Body fat, percent |
30.4±5 | 20.1-43.2 |
|
Fat-free body mass, kg |
43.8±4 |
36.4-54 |
| Fat mass, kg | 19.4±5 | 11.1-39.8 |
|
Measured RMR range, kcal per day |
1,302±100 |
1,094-1,513 |
- Location: University of Vermont.
Major Results
- Potential predictors of RMR were: Standing height, body weight, body surface area, body mass index, fat mass, fat-free mass, four skinfolds, VO2 max, leisure time physical activity, daily energy and macronutrient intake, menstrual status and age
- Correlations (r) with RMR:
- Age: -0.26
- Height: 0.48
- Weight 0.68
- Fat free mass: 0.89
- Leisure-time activity: -0.09
- VO2 max: 0.42
- Fat-free mass was the strongest and only significant predictor of RMR in the total group of 75 older women (R=0.89; P<0.01); explaining 79% of the total variance. In a laboratory setting, the measurement of FFM predicted RMR in older women within ±46kcal per day.
- Regression equation: RMR (kcal per day)=21 (FFM, kg) + 369 (r2=0.79) (SEE= ±46kcal per day)
- Focus of the study was to develop a simple equation for predicting RMR after removal of variables deemed impractical or difficult to measure (i.e., FFM) in a clinical (non-research) setting. A practical equation was derived in which only easily measured variables were considered: Body weight, standing height, age, skinfolds, menstrual status and leisure time physical activity.
- Of these variables, body weight (kg) accounted for 47% of total variance in RMR (R=0.68; P<0.01)
- Standing height (cm) explained an additional 8% of variance in RMR
- Menopausal status explained 4% of total variance
- Together, the three variables—weight, standing height and menopausal status accounted for 59% (R2) of the variance in RMR and the new practical equation predicted RMR within ±66kcal per day, P<0.01
- Regression equation for this sample: RMR (kcal per day)=7.8 (weight, kg) + 4.7 (standing height, cm) - 39.5 (menopausal status, 1,2,3) + 144 (R=0.77, R2=0.59, SEE=66kcal per day, P<0.01)
- Of these variables, body weight (kg) accounted for 47% of total variance in RMR (R=0.68; P<0.01)
Cross-validation results
- Harris-Benedict underestimated (7%) RMR in older population; differences not significant
- Owen et al significantly (P<0.05) under-predicted RMR by an average of 5% (group); with a range of -27% to 15% on an individual basis
- Mifflin et al significantly (P<0.05) under-predicted measured RMR by 11% (group); ranging from -31% to 7%
- WHO/FAO and Fredrix et al (P<0.05) overestimated measured RMR by 3%; ranging from -8% to 12% and -24% to 20%, respectively
- WHO/FAO predicted RMR in older women with SEE of ±94kcal per day compared to ±66kcal per day in this study
- Outpatient conditions in Fredrix study may have contributed to overestimated RMR; in previous study done by author, outpatient overestimated by approximately 8% compared with inpatient conditions.
| Study | Original equation |
| WHO (females, N=NA>60 years) | RMR (kcal per day)=[9.2 (W) + 6.4(H)] -302 (R2=0.67) |
| Harris Benedict (females, N=16>50 years) | RMR (kcal per day)=[1.8 (H) + 9.6 (W) - 4.7 (A)] +655 (R2=0.59) |
| Owen et al (females, N=8>50 years) | RMR (kcal per day)=[7.2 (W)] +795 (R2=0.55) |
| Fredrix et al (females, (N=22>50 years) | RMR (kcal per day)=[10.7 (W) - 9 (A) - 203 (2)] + 1641 (R2=0/84) |
| Mifflin et al (females, N=50>50 years) | RMR (kcal per day)=[10 (W) + 6.25 (H)=5 (A)] - 161 (R2=0.71) |
| Arciero et al (females, N=75>50 years) | RMR (kcal per day)=[7.8 (W) + 4.7 (H) - 40 (M)] +144 (R2=0.59) |
Units for equations: W: Weight, kg; H: Height, cm; A: Age; M: Menopausal, 1=pre, 2=peri, 3=post; NA=not available
| Criterion #1 | Criterion #2 | |||
| Study | Measured (kcal per day) |
Predicted (kcal per day) |
P-value | r vs. R |
| WHO (>60 years) | 1,286.6 | 1,320.0 | 0.12 | 0.79 vs. 0.82 |
| Harris-Benedict | 1,301.6 | 1,274.6 | 0.07 | 0.75 vs. 0.78 |
| Owen | 1,301.6 | 1,249.2 | <0.01 | 0.68 vs. 0.74* |
| Fredrix | 1,301.6 | 1,359.3 | <0.01 | 0.69 vs. 0.92* |
| Mifflin | 1,301.6 | 1,185.3 | <0.01 | 0.75 vs. 0.84* |
* correlation coefficient is significantly different from the multiple R, P<0.05
- Currently available equations to predict RMR in older individuals have not been age- or sex-specific, have generally been based on data extrapolated from younger individuals, and have relied generally on small sample sizes (N=50)
- In a laboratory setting, the measurement of FFM predicted RMR in older women within ±46kcal per day
- However, in a clinical or non-research setting; body weight alone best predicted RMR, accounting for 47% of the explained variance in RMR in older females. The use of body weight alone would permit an estimate of RMR with a standard error of estimate of ±74kcal per day
- Standing height significantly (R2=8%) strengthened the prediction of RMR and addition of menopausal status contributed an additional 4% of explained variance. The independent two (variables (plus body weight) increased the R2 to 59%, which would permit an estimate of RMR within ±66kcal per day
- There was a significant linear decline in RMR in females >50 years of age with onset of menopause
- Because of finding that menopausal status is a significant factor contributing to the variation in RMR in older women (hormone status), authors suggested may need to develop separate equations for older men and women
- When five previously published equations were applied to predict RMR in cross validation-independent predicted values deviated by -31% to 20% from the measured values
- With the exception of the WHO/FAO equation and the Harris-Benedict equation, none of the published equations cross-validated successfully with the measured RMR values from the 75 older women. The WHO/FAO equation predicted RMR in older women with a standard error of estimate of ±94kcal per day compared with ±66kcal per day in the present age- and sex-specific equation.
Major Conclusion
“In summary, we offer an accurate equation to predict RMR in older women that is both age-specific and practical for use in the clinical or non-research setting using body weight, standing height and menopausal status.”
| Government: | NIH |
Strengths
- Large sample size in comparison to other studies
- Inpatient conditions
- Measurement standardized for optimum basal conditions
- IC measurements performed 36-48 hours after last exercise bout to avoid effects of exercise on RMR
- Subjects familiarized with equipment prior to study to minimize anxiety.
Limitations
- Caucasians
- Healthy older women
- So limited generalizability; can’t apply findings to females in other age or ethnic groups
- Cross-sectional; no cause and effects
- Small sample of “oldest old” >80 years
- Direct measurements recommended for precise measurements of RMR
- Self-selection bias with convenience sample; may be different than general population
- With diet diaries and weighed diet; may alter diet; not usual diet; may pick foods easier to weigh and measure
- Large range of calorie intake among participants; range 1,000-3,223kcal per day; mean 1,758±429kcal per day which could affect results; not mentioned what effect it had on RMR (?)
- Large range of leisure time activity; range 77-839kcal per day; mean 263±166kcal per day); not mentioned what effect it had on RMR (?)
- Not sure why collected data on variables that were considered by authors as impractical or hard to measure.
If height and weight were significant predictors, what about BMI?
|
Quality Criteria Checklist: Primary Research
|
|||
| Relevance Questions | |||
| 1. | Would implementing the studied intervention or procedure (if found successful) result in improved outcomes for the patients/clients/population group? (Not Applicable for some epidemiological studies) | Yes | |
| 2. | Did the authors study an outcome (dependent variable) or topic that the patients/clients/population group would care about? | Yes | |
| 3. | Is the focus of the intervention or procedure (independent variable) or topic of study a common issue of concern to dieteticspractice? | Yes | |
| 4. | Is the intervention or procedure feasible? (NA for some epidemiological studies) | Yes | |
| Validity Questions | |||
| 1. | Was the research question clearly stated? | Yes | |
| 1.1. | Was (were) the specific intervention(s) or procedure(s) [independent variable(s)] identified? | Yes | |
| 1.2. | Was (were) the outcome(s) [dependent variable(s)] clearly indicated? | Yes | |
| 1.3. | Were the target population and setting specified? | Yes | |
| 2. | Was the selection of study subjects/patients free from bias? | ??? | |
| 2.1. | Were inclusion/exclusion criteria specified (e.g., risk, point in disease progression, diagnostic or prognosis criteria), and with sufficient detail and without omitting criteria critical to the study? | Yes | |
| 2.2. | Were criteria applied equally to all study groups? | Yes | |
| 2.3. | Were health, demographics, and other characteristics of subjects described? | Yes | |
| 2.4. | Were the subjects/patients a representative sample of the relevant population? | ??? | |
| 3. | Were study groups comparable? | Yes | |
| 3.1. | Was the method of assigning subjects/patients to groups described and unbiased? (Method of randomization identified if RCT) | N/A | |
| 3.2. | Were distribution of disease status, prognostic factors, and other factors (e.g., demographics) similar across study groups at baseline? | N/A | |
| 3.3. | Were concurrent controls or comparisons used? (Concurrent preferred over historical control or comparison groups.) | N/A | |
| 3.4. | If cohort study or cross-sectional study, were groups comparable on important confounding factors and/or were preexisting differences accounted for by using appropriate adjustments in statistical analysis? | Yes | |
| 3.5. | If case control study, were potential confounding factors comparable for cases and controls? (If case series or trial with subjects serving as own control, this criterion is not applicable.) | N/A | |
| 3.6. | If diagnostic test, was there an independent blind comparison with an appropriate reference standard (e.g., "gold standard")? | N/A | |
| 4. | Was method of handling withdrawals described? | No | |
| 4.1. | Were follow-up methods described and the same for all groups? | N/A | |
| 4.2. | Was the number, characteristics of withdrawals (i.e., dropouts, lost to follow up, attrition rate) and/or response rate (cross-sectional studies) described for each group? (Follow up goal for a strong study is 80%.) | No | |
| 4.3. | Were all enrolled subjects/patients (in the original sample) accounted for? | ??? | |
| 4.4. | Were reasons for withdrawals similar across groups? | ??? | |
| 4.5. | If diagnostic test, was decision to perform reference test not dependent on results of test under study? | N/A | |
| 5. | Was blinding used to prevent introduction of bias? | No | |
| 5.1. | In intervention study, were subjects, clinicians/practitioners, and investigators blinded to treatment group, as appropriate? | No | |
| 5.2. | Were data collectors blinded for outcomes assessment? (If outcome is measured using an objective test, such as a lab value, this criterion is assumed to be met.) | No | |
| 5.3. | In cohort study or cross-sectional study, were measurements of outcomes and risk factors blinded? | No | |
| 5.4. | In case control study, was case definition explicit and case ascertainment not influenced by exposure status? | N/A | |
| 5.5. | In diagnostic study, were test results blinded to patient history and other test results? | N/A | |
| 6. | Were intervention/therapeutic regimens/exposure factor or procedure and any comparison(s) described in detail? Were interveningfactors described? | Yes | |
| 6.1. | In RCT or other intervention trial, were protocols described for all regimens studied? | N/A | |
| 6.2. | In observational study, were interventions, study settings, and clinicians/provider described? | Yes | |
| 6.3. | Was the intensity and duration of the intervention or exposure factor sufficient to produce a meaningful effect? | Yes | |
| 6.4. | Was the amount of exposure and, if relevant, subject/patient compliance measured? | N/A | |
| 6.5. | Were co-interventions (e.g., ancillary treatments, other therapies) described? | N/A | |
| 6.6. | Were extra or unplanned treatments described? | N/A | |
| 6.7. | Was the information for 6.4, 6.5, and 6.6 assessed the same way for all groups? | N/A | |
| 6.8. | In diagnostic study, were details of test administration and replication sufficient? | N/A | |
| 7. | Were outcomes clearly defined and the measurements valid and reliable? | ??? | |
| 7.1. | Were primary and secondary endpoints described and relevant to the question? | Yes | |
| 7.2. | Were nutrition measures appropriate to question and outcomes of concern? | Yes | |
| 7.3. | Was the period of follow-up long enough for important outcome(s) to occur? | Yes | |
| 7.4. | Were the observations and measurements based on standard, valid, and reliable data collection instruments/tests/procedures? | ??? | |
| 7.5. | Was the measurement of effect at an appropriate level of precision? | Yes | |
| 7.6. | Were other factors accounted for (measured) that could affect outcomes? | Yes | |
| 7.7. | Were the measurements conducted consistently across groups? | Yes | |
| 8. | Was the statistical analysis appropriate for the study design and type of outcome indicators? | Yes | |
| 8.1. | Were statistical analyses adequately described and the results reported appropriately? | Yes | |
| 8.2. | Were correct statistical tests used and assumptions of test not violated? | Yes | |
| 8.3. | Were statistics reported with levels of significance and/or confidence intervals? | Yes | |
| 8.4. | Was "intent to treat" analysis of outcomes done (and as appropriate, was there an analysis of outcomes for those maximally exposed or a dose-response analysis)? | N/A | |
| 8.5. | Were adequate adjustments made for effects of confounding factors that might have affected the outcomes (e.g., multivariate analyses)? | Yes | |
| 8.6. | Was clinical significance as well as statistical significance reported? | Yes | |
| 8.7. | If negative findings, was a power calculation reported to address type 2 error? | N/A | |
| 9. | Are conclusions supported by results with biases and limitations taken into consideration? | Yes | |
| 9.1. | Is there a discussion of findings? | Yes | |
| 9.2. | Are biases and study limitations identified and discussed? | Yes | |
| 10. | Is bias due to study's funding or sponsorship unlikely? | Yes | |
| 10.1. | Were sources of funding and investigators' affiliations described? | Yes | |
| 10.2. | Was the study free from apparent conflict of interest? | Yes | |